By Jason T. Gammack, CEO
Legacy vendors ship excuses. We ship DNA — reliability guaranteed.
If your research depends on DNA, you know the frustration: sliding timelines, added fees, and the email no one wants to read — ‘One or more of your sequences failed synthesis…’ Funny how their excuses always arrive on time. Sadly, your DNA doesn’t.
That isn’t a partnership. That’s obstruction. Your science deserves better.
Legacy synthesis providers haven’t kept pace with the demands of modern research. Their limitations have become your limitations. At Ansa, we refuse to accept that. We built a platform from the ground up to deliver the DNA you need, when you need it – not excuses.
And now we’re raising the bar again: transparent, value-based pricing, expanded access to 50kb DNA synthesis, and a guarantee that holds us accountable in ways no one else dares.
Pricing, Straight Up
For too long, DNA pricing has been a mess, with add-on cloning fees, setup charges, and special handling fees that left scientists guessing and frustrated. That ends now.
Pricing at Ansa is transparent, predictable, and tied to the value of what we deliver: length and complexity. If your project is straightforward, you pay the standard price. If it’s complex or large, the price reflects the work, but you’ll know the number before you hit submit. No more second-guessing or hidden surprises; just simplicity and transparency.
Standard clonal DNA starts at $0.13 per base pair, scaling logically with length and complexity, all the way up to 50kb clonal genes, which are available as a pre-commercial, early access product at $0.28 per base pair.
It’s transparent. It’s fair. It’s designed so you can plan your science — and your budgets — without second-guessing.
50kb: A reality today
When we launched last year, we came out swinging at the hardest problems impacting your science — GC-rich monsters, repeat-heavy beasts, and the designs other shops flat-out refused. That’s how we proved the power of our platform.
But here’s the real headline: Going from 600 bp to 50 kb in 18 months isn’t just a technical milestone, it’s unleashing entirely new classes of applications that were out of reach before.
Earlier this year, we launched an invitation-only early access program, partnering with pioneers from The Allen Institute, Terrain Bio, Harvard University, the University of Washington, New York University, and other notable institutions. Together, we pushed the platform to deliver the most demanding constructs science had to offer, producing them reliably at scale.
As Dr. Aaron Larsen, CSO of Terrain Bio, put it:
“Ansa has been a consistent, responsive, and reliable partner… delivering highly complex DNA constructs that enable us to build complex and lengthy mRNA sequences. Their 7.5kb–50kb clonal gene offering enables us to push the limits of mRNA design and manufacturing.”
Now we’re ready for more. Any lab, any project, any scientist who needs ≤50kb in ≤25 days can tap into this capability. Whether your application is genome synthesis, metabolic engineering, or building model organisms, the scale of what’s possible has just expanded.
Ansa On-Time Guarantee
We’re upending the entire synthetic DNA ordering process. Get your complete order on time, or it’s free. Learn more.
Reliability: Ansa delivers on our commitments, or everything is free
Of course, none of this matters if you can’t count on delivery. Which brings us to the Ansa On Time Guarantee.
Here’s the reality: Ansa delivers 97.6% of all orders. And when we miss, you don’t pay; your entire order is free of charge. No other vendor has the courage to put their business on the line like this, because no one else has built a platform that can back it up.
The Ansa On Time Guarantee isn’t just a marketing line; it’s a forcing function. It keeps us honest. It pushes us to get better every single day. It makes reliability not just a promise but a metric we live or die by.
This is what sets Ansa apart: we’re not afraid to be accountable.
Looking Ahead
One year into commercialization, we’ve evolved from a company you probably hadn’t heard of to one setting the new standard: transparent pricing, ultra-long DNA, and reliability you can take to the bank.
We’re proud of the progress, but this isn’t a victory lap; it’s a foundation. The real story is what you’ll do with it. If the last year was about proving what’s possible, the next is about scaling discovery across the scientific community. The real question is, what will you build now that excuses are no longer in your way?
The excuses are gone. Your DNA is available. Ansa Biotechnologies. Expect more.